pf-05212372
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2010 (NCT01415102)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pf-05212372
- zpl-5212372
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02795832 | Phase 1/Phase 2 (Phase 2) | Jun 1, 2016 | Ziarco Pharma Ltd |
| NCT01415102 | Phase 1 | Sep 1, 2010 | Pfizer |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 1 | 1 | 1 | 2010 |
| Ziarco Pharma Ltd | For profit | 1 | 1 | 1 | 2016 |
2 organizations
Page 1 / 1